Logo

Our Mission

is to raise funds to support breast cancer research, clinical trials, education, and patient care.

Donate

Our Approach is Simple:

it starts with you.

Feature Trial

BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation

Breaking it down:

Is there a non-surgical way to reduce breast cancer risk in women with a BRCA1 mutation?

Eligibility Criteria:

  1. Women who have a confirmed BRCA1 gene mutation (variant)
  2. 25 to 55 years of age
  3. Do NOT have a history of breast or ovarian cancer
  4. Not pregnant or breastfeeding
  5. Have not had a mastectomy

Treatments:

  • Subcutaneous (SQ) injection under the skin of denosumab or
  • Placebo once every 6 months for 5 years

Drugs used:

  • Denosumab is a well-tolerated drug approved by the FDA to treat osteoporosis in healthy people and in cancer patients whose cancer has spread to their bones. Side effects include muscle and bone pain, shortness of breath, and low levels of calcium and phosphate in the blood.

Locations and Contacts:

30 locations through-out the United States, include Pittsburgh.

  • Carol Glock M.Ed
    Phone: 412-680-6496
  • Cortney Montgomery BSN, RN, CCRP, CBCN
    Phone: 412-641-1840

Your Contribution...

Assists breast cancer clinical trial patients with the added cost for transportation, meals and child care.
medicine
Provides educational opportunities for breast cancer physicians to attend a symposium about current clinical trials.
Educates the general public on breast cancer prevention, detection, treatment and clinical trials.

Feature

Updates

Allegheny Health Network currently has 13 Active Breast Cancer Clinicals Trials

More Details

What's New in Breast Cancer 2024

Update

When:
Sat. May 18, 2024
Where:
LeMont Restaurant, Mt. Washington
Fee:
$20 for General Admission
$40 for Healthcare Professional
$80 for Physician
Register

Highmark Walk - 2024

Update

The 2024 Highmark Walk for a Healthy Community will be held on:

June 22, 2024 at Stage AE, North Shore, Pittsburgh.

Join the Glock Foundation and walk to support breast cancer clinical trials, education, and patient financial assistance.

Register

W&J Pink Out Game

Update

Thank You to the women’s basketball team of Washington and Jefferson College for raising $2802.00 on February 3, 2024, at the Pink Out Game. The money raised will help young breast cancer survivors.

Community Outreach Programs

  • Learn 5 Strategies for Prevention and Treatment of Breast Cancer
  • Why Me, Cancer is Only One Chapter of a Person’s Life
  • Benefits of Participating in a Breast Cancer Clinical Trial
Breast cancer is the most commonly occurring cancer, and the second most common cause of cancer deaths in women in the United States.
(National Cancer Institute, 2017)

Press

Life-Changeing

A Life Changing Addition for One Pennsylvania Family

The Glock Foundaton is honored to have contributed monies to Canine Service Pals along with the Young Women’s Breast Cancer Awareness Foundation to bring home Oreo a trained service dog exclusively for Cara Snyder’s family.

I Had Cancer Podcast - Investigational Drug Eliminates Breast Cancer

Carol discovered a walnut-size lump in her breast and was diagnosed with inflammatory breast cancer, which is rare and aggressive and carries a 20 percent chance of survival. Carol talks about how a clinical trial at AHN helped her beat the odds.

Living Proof: Allegheny Health Network Together with Johns Hopkins

Carol Glock is featured in an Allegheny Health Network and Johns Hopkins living proof commerical.

If you want to discuss clinical trials or schedule a community outreach presentation please contact us at:

Phone: (412) 680-6496Contact us

Affiliations

AHN
NSABP
BPP
Face2Face
KJ
BreastCancerTrialsOrg